| Literature DB >> 36107511 |
Saori Morino1, Hinako Hirata2, Daisuke Matsumoto3, Isao Yokota4, Tomoki Aoyama2.
Abstract
Premenstrual syndrome (PMS) has a wide variety of symptoms. The classification of these symptoms into several patterns is useful for more effective tailor-made treatment. Therefore, our study aimed to examine the patterns of PMS by analyzing multiple factors to identify the characteristics of each pattern. This is a cross-sectional study. A total of 165 women (18.9 ± 1.0 years) were investigated by using of questionnaire about PMS, nutrition, physical activity, and other lifestyle traits. Then, the factor analysis was performed to classify the premenstrual symptoms, that is, the pattern of PMS. Additionally, logistic regression analysis was performed to identify the characteristics of each pattern, adjusted for age, body mass index, sleep duration, and caffeine intake. As the result, PMS was classified into 3 patterns. The type related to psychological symptoms such as depression, physiological symptoms, such as abdominal pain, and intermingled type, were labeled as affected, somatic, and mixed types, respectively. From the result of logistic regression analysis, self-rating depression scale scoring was marginally associated with affective type (odds ratio [OR]: 1.08, 95% confidence interval [CI]: 0.99-1.16), physical activity was significantly associated with the mixed type (OR: 1.13, 95% CI: 1.00-1.28), and physical activity (OR: 1.20, 95% CI: 1.05-1.36) and some nutrients (OR: 0.56-1.00) were significantly associated with the somatic type. Understanding PMS and management of these complicated symptoms has been difficult. From the results of this study, the complicated symptoms were categorized into simpler patterns. Our findings may contribute to the understanding and possible management adjusted for each categorized case of PMS.Entities:
Mesh:
Substances:
Year: 2022 PMID: 36107511 PMCID: PMC9439839 DOI: 10.1097/MD.0000000000030186
Source DB: PubMed Journal: Medicine (Baltimore) ISSN: 0025-7974 Impact factor: 1.817
Participants characteristic.
| All participants (n = 165) | |
|---|---|
| Age (y) | 18.9 ± 1.0 |
| BMI (kg/m2) | 21.8 ± 3.8 |
| Sleep duration (min) | 364.5 ± 55.9 |
| Caffeine beverage (g/day) | 334.5 ± 292.5 |
BMI = body mass index.
Factor loading of each PMS symptom.
| Factor 1 | Factor 2 | Factor 3 | |
|---|---|---|---|
| Anxiety |
| 0.183 | 0.177 |
| Confusion |
| 0.224 | 0.306 |
| Depression |
| 0.328 | 0.474 |
| Social withdrawal |
| 0.439 | −0.016 |
| Angry outbursts |
| 0.337 | 0.330 |
| Skin problems |
| 0.216 | 0.240 |
| Poor motivation | 0.256 |
| 0.045 |
| Poor concentration | 0.281 |
| 0.156 |
| Fatigability | 0.312 |
| 0.432 |
| Abdominal bloating | 0.209 |
| 0.273 |
| Drowsiness | 0.222 |
| 0.394 |
| Low back pain | 0.090 |
| 0.380 |
| Swelling of the hands or feet | 0.269 |
| 0.280 |
| Increased appetite | 0.313 |
| 0.273 |
| Irritability | 0.420 | 0.288 |
|
| Breast tenderness or pain | 0.282 | 0.027 |
|
| Abdominal pain | 0.038 | 0.361 |
|
| Headache | 0.299 | 0.172 |
|
| Contribution ratio | 43.70% | 8.18% | 7.05% |
Bartlett test of sphericity and KMO test were done to determine whether there were sufficient significant correlations among the items. Bartlett test of sphericity was highly significant (P < .01), indicating that the 18-item correlation matrix was not an identity matrix. In addition, the KMO value of 0.910 met Kaiser middling criteria’, which is > 0.6. The data in bold means there are sufficient significant correlations among the items.
PMS = premenstrual syndrome, KMO = Kaisar-Meyer-Olkin.
Figure 1.The strategy of patterns of PMS symptoms. PMS = premenstrual syndrome.
Logistic regression analysis for investigating relative factors for each PMS pattern.
| Affective type | Mixed type | Somatic type | ||||
|---|---|---|---|---|---|---|
| OR | 95% CI | OR | 95% CI | OR | 95% CI | |
| 1.04 | 0.91–1.19 |
|
|
|
| |
| SDS score (points) | 1.08 | 0.99–1.16 | 1.04 | 0.97–1.10 | 1.05 | 0.98–1.11 |
| Protein (g/day) | 1.00 | 0.98–1.01 | 1.00 | 0.98–1.00 | 0.99 | 0.97–1.00 |
| Lipid (g/day) | 1.00 | 0.98–1.01 | 1.00 | 0.98–1.01 | 0.99 | 0.97–1.00 |
| Carbohydrate (g/day) | 1.00 | 0.99–1.00 | 1.00 | 0.99–1.00 | 1.00 | 0.98–1.00 |
| Sodium (mg/day) | 1.00 | 1.00–1.00 | 1.00 | 1.00–1.00 | 1.00 | 0.99–1.00 |
| Potassium (mg/day) | 1.00 | 1.00–1.00 | 1.00 | 1.00–1.00 | 1.00 | 0.99–1.00 |
| Calcium (mg/day) | 1.00 | 0.99–1.00 | 1.00 | 0.99–1.00 | 1.00 | 0.99–1.00 |
| Magnesium (mg/day) | 1.00 | 0.99–1.00 | 1.00 | 0.99–1.00 | 1.00 | 0.99–1.00 |
| Phosphorus (mg/day) | 1.00 | 0.99–1.00 | 1.00 | 0.99–1.00 | 1.00 | 0.99–1.00 |
| Iron (mg/day) | 0.97 | 0.84–1.11 | 1.00 | 0.90–1.11 | 0.87 | 0.75–1.00 |
| Zinc (mg/day) | 0.96 | 0.83–1.11 | 0.98 | 0.87–1.09 | 0.92 | 0.80–1.04 |
| Cuprous (mg/day) | 0.70 | 0.21–2.29 | 0.91 | 0.36–2.27 | 0.37 | 0.11–1.14 |
| 0.61 | 0.30–1.20 | 0.93 | 0.59–1.47 |
|
| |
| Retinol (μg/day) | 1.00 | 0.99–1.00 | 1.00 | 0.99–1.00 | 1.00 | 0.99–1.00 |
| Vitamin D (mg/day) | 0.99 | 0.94–1.03 | 1.00 | 0.96–1.02 | 0.98 | 0.93–1.01 |
| α Tocopherol (mg/day) | 0.97 | 0.84–1.11 | 1.00 | 0.90–1.11 | 0.87 | 0.75–1.00 |
| Vitamin K (μg/day) | 1.00 | 0.99–1.00 | 1.00 | 0.99–1.00 | 1.00 | 0.99–1.00 |
| Vitamin B1 (mg/day) | 0.65 | 0.17–2.46 | 0.88 | 0.32–2.37 | 0.44 | 0.13–1.45 |
| Vitamin B2 (mg/day) | 1.08 | 0.48–2.39 | 1.06 | 0.54–2.06 | 0.68 | 0.31–1.47 |
| Niacin (mg/day) | 0.98 | 0.92–1.04 | 0.99 | 0.95–1.03 | 0.97 | 0.92–1.02 |
| Vitamin B6 (mg/day) | 0.79 | 0.36–1.71 | 0.99 | 0.55–1.75 | 0.58 | 0.28–1.21 |
| Vitamin B12 (μg/day) | 0.98 | 0.91–1.04 | 1.00 | 0.94–1.04 | 0.97 | 0.91–1.02 |
| 1.00 | 0.99–1.00 | 1.00 | 0.99–1.00 |
|
| |
| Pantothenic acid (mg/day) | 1.01 | 0.85–1.18 | 1.00 | 0.87–1.13 | 0.92 | 0.78–1.06 |
| 1.00 | 0.99–1.00 | 1.00 | 0.99–1.00 |
|
| |
| Saturated fatty acid (g/day) | 1.01 | 0.95–1.06 | 0.99 | 0.93–1.03 | 0.98 | 0.92–1.02 |
| Monounsaturated fatty acid (g/day) | 1.00 | 0.95–1.04 | 0.99 | 0.94–1.03 | 0.98 | 0.93–1.02 |
| Polyunsaturated fatty acid (g/day) | 0.99 | 0.91–1.07 | 0.98 | 0.91–1.05 | 0.95 | 0.87–1.02 |
| Cholesterol (mg/day) | 1.00 | 0.99–1.00 | 1.00 | 0.99–1.00 | 1.00 | 0.99–1.00 |
| 0.98 | 0.89–1.07 | 1.01 | 0.93–1.08 |
|
| |
| Sodium chloride (g/day) | 0.96 | 0.83–1.09 | 0.96 | 0.85–1.06 | 0.92 | 0.81–1.03 |
| Sucrose (g/day) | 1.03 | 0.97–1.08 | 1.00 | 0.96–1.05 | 0.98 | 0.93–1.02 |
| Daidzein (mg/day) | 1.04 | 0.98–1.10 | 1.00 | 0.94–1.05 | 0.98 | 0.93–1.04 |
| Genistein (mg/day) | 1.02 | 0.98–1.06 | 1.00 | 0.96–1.03 | 0.99 | 0.95–1.02 |
| Cryptoxanthin (μg/day) | 1.00 | 0.99–1.00 | 1.00 | 0.99–1.00 | 1.00 | 0.99–1.00 |
| β Tocopherol (mg/day) | 0.81 | 0.03–1.81 | 0.24 | 0.01–4.22 | 0.25 | 0.01–4.43 |
| γ Tocopherol (mg/day) | 0.99 | 0.91–1.08 | 0.98 | 0.91–1.05 | 0.95 | 0.87–1.02 |
| δ Tocopherol (mg/day) | 1.07 | 0.75–1.52 | 0.96 | 0.70–1.31 | 0.84 | 0.60–1.17 |
The dependent variable was being each type. Noneach type = 0, each type = 1. The multivariate analysis was adjusted for BMI, sleeping time, alcohol, and caffeine except for physical activity. In physical activity, the multivariate analysis was adjusted for height, sleeping time, alcohol, and caffeine. The data in bold are statistically significant.
BMI = body mass index, OR = odds ratio, SDS = self-depression scale.
P < .05.
P < .01.